First, an experimental model of OVA-induced AHR, airway eosinophilia, and type 2 cytokine production was used to monitor the activities of CCL20 and CCR6+ Treg cells (Figure 4A, B). The gene discussed is CCL20; the disease is Increased total eosinophil count.